Search

Your search keyword '"Yasuda, Ichiro"' showing total 1,653 results
Start Over Author "Yasuda, Ichiro"
1,653 results on '"Yasuda, Ichiro"'

2. WONDER-02: plastic stent vs. lumen-apposing metal stent for endoscopic ultrasound-guided drainage of pancreatic pseudocysts—study protocol for a multicentre randomised non-inferiority trial

Author

Saito, Tomotaka, Takenaka, Mamoru, Kuwatani, Masaki, Doi, Shinpei, Ohyama, Hiroshi, Fujisawa, Toshio, Masuda, Atsuhiro, Iwashita, Takuji, Shiomi, Hideyuki, Hayashi, Nobuhiko, Iwata, Keisuke, Maruta, Akinori, Mukai, Tsuyoshi, Matsubara, Saburo, Hamada, Tsuyoshi, Inoue, Tadahisa, Matsumoto, Kazuyuki, Hirose, Sumio, Fujimori, Nao, Kashiwabara, Kosuke, Kamada, Hideki, Hashimoto, Shinichi, Shiratori, Toshiyasu, Yamada, Reiko, Kogure, Hirofumi, Nakahara, Kazunari, Ogura, Takeshi, Kitano, Masayuki, Yasuda, Ichiro, Isayama, Hiroyuki, and Nakai, Yousuke

Published
2024
Full Text
View/download PDF

6. Artificial intelligence–based skeletal muscle estimates and outcomes of EUS-guided treatment of pancreatic fluid collections

Author

Sakai, Arata, Nakano, Ryota, Iwasa, Yuhei, Takenaka, Mamoru, Gonoi, Wataru, Sato, Tatsuya, Saito, Tomotaka, Hanaoka, Shouhei, Hamada, Tsuyoshi, Omoto, Shunsuke, Masuda, Atsuhiro, Tsujimae, Masahiro, Iwashita, Takuji, Uemura, Shinya, Ota, Shogo, Shiomi, Hideyuki, Fujisawa, Toshio, Takahashi, Sho, Matsubara, Saburo, Suda, Kentaro, Maruta, Akinori, Yoshida, Kensaku, Iwata, Keisuke, Okuno, Mitsuru, Hayashi, Nobuhiko, Mukai, Tsuyoshi, Isayama, Hiroyuki, Yasuda, Ichiro, and Nakai, Yousuke

Published
2024
Full Text
View/download PDF

8. Evidence-based clinical practice guidelines for cholelithiasis 2021

Author

Fujita, Naotaka, Yasuda, Ichiro, Endo, Itaru, Isayama, Hiroyuki, Iwashita, Takuji, Ueki, Toshiharu, Uemura, Kenichiro, Umezawa, Akiko, Katanuma, Akio, Katayose, Yu, Suzuki, Yutaka, Shoda, Junichi, Tsuyuguchi, Toshio, Wakai, Toshifumi, Inui, Kazuo, Unno, Michiaki, Takeyama, Yoshifumi, Itoi, Takao, Koike, Kazuhiko, and Mochida, Satoshi

Published
2023
Full Text
View/download PDF

11. WONDER-01: immediate necrosectomy vs. drainage-oriented step-up approach after endoscopic ultrasound-guided drainage of walled-off necrosis—study protocol for a multicentre randomised controlled trial

Author

Sato, Tatsuya, Saito, Tomotaka, Takenaka, Mamoru, Iwashita, Takuji, Shiomi, Hideyuki, Fujisawa, Toshio, Hayashi, Nobuhiko, Iwata, Keisuke, Maruta, Akinori, Mukai, Tsuyoshi, Masuda, Atsuhiro, Matsubara, Saburo, Hamada, Tsuyoshi, Inoue, Tadahisa, Ohyama, Hiroshi, Kuwatani, Masaki, Kamada, Hideki, Hashimoto, Shinichi, Shiratori, Toshiyasu, Yamada, Reiko, Kogure, Hirofumi, Ogura, Takeshi, Nakahara, Kazunari, Doi, Shinpei, Chinen, Kenji, Isayama, Hiroyuki, Yasuda, Ichiro, and Nakai, Yousuke

Published
2023
Full Text
View/download PDF

13. ERCP using balloon-assisted endoscopes versus EUS-guided treatment for common bile duct stones in Roux-en-Y gastrectomy

Author

Sato, Tatsuya, Nakai, Yousuke, Kogure, Hirofumi, Mitsuyama, Toshiyuki, Shimatani, Masaaki, Uemura, Shinya, Iwashita, Takuji, Tanisaka, Yuki, Ryozawa, Shomei, Tsuchiya, Takayoshi, Itoi, Takao, Kin, Toshifumi, Katanuma, Akio, Kashima, Ken, Irisawa, Atsushi, Kayashima, Atsuto, Iwasaki, Eisuke, Yoshida, Akihiro, Takenaka, Mamoru, Himei, Hitomi, Kato, Hironari, Masuda, Atsuhiro, Shiomi, Hideyuki, Kawakubo, Kazumichi, Kuwatani, Masaki, Otsuka, Takeshi, Matsubara, Saburo, Nishioka, Nobu, Ogura, Takeshi, Tamura, Takaaki, Kitano, Masayuki, Hayashi, Nobuhiko, Yasuda, Ichiro, and Fujishiro, Mitsuhiro

Published
2024
Full Text
View/download PDF

15. Utility of bilateral intraductal plastic stent for malignant hilar biliary obstruction compared with bilateral self-expandable metal stent: a propensity score–matched cohort analysis

Author

Okuno, Mitsuru, Iwata, Keisuke, Iwashita, Takuji, Mukai, Tsuyoshi, Shimojo, Kota, Ohashi, Yosuke, Iwasa, Yuhei, Senju, Akihiko, Iwata, Shota, Tezuka, Ryuichi, Ichikawa, Hironao, Mita, Naoki, Uemura, Shinya, Yoshida, Kensaku, Maruta, Akinori, Tomita, Eiichi, Yasuda, Ichiro, and Shimizu, Masahito

Published
2023
Full Text
View/download PDF

17. Supportive treatment during the periprocedural period of endoscopic treatment for pancreatic fluid collections: a critical review of current knowledge and future perspectives

Author

Iwashita, Takuji, Iwata, Keisuke, Hamada, Tsuyoshi, Saito, Tomotaka, Shiomi, Hideyuki, Takenaka, Mamoru, Maruta, Akinori, Uemura, Shinya, Masuda, Atsuhiro, Matsubara, Saburo, Mukai, Tsuyoshi, Takahashi, Sho, Hayashi, Nobuhiko, Isayama, Hiroyuki, Yasuda, Ichiro, and Nakai, Yousuke

Published
2023
Full Text
View/download PDF

18. Estimating the population mean for a vertical profile of energy dissipation rate

Author

Sugiura, Nozomi, Kouketsu, Shinya, Masuda, Shuhei, Osafune, Satoshi, and Yasuda, Ichiro

Subjects
Physics - Geophysics, Physics - Atmospheric and Oceanic Physics, Physics - Data Analysis, Statistics and Probability
Abstract

Energy dissipation rates are an important characteristic of turbulence; however, their magnitude in observational profiles can be incorrectly determined owing to their irregular appearance during vertical evolution. By analysing the data obtained from oceanic turbulence measurements, we demonstrate that the vertical sequences of energy dissipation rates exhibit a scaling property. Utilising this property, we propose a method to estimate the population mean for a profile. For scaling in the observed profiles, we demonstrate that our data exhibit a statistical property consistent with that exhibited by the universal multifractal model. Meanwhile, the population mean and its uncertainty can be estimated by inverting the probability distribution obtained by Monte Carlo simulations of a cascade model; to this end, observational constraints from several moments are imposed over each vertical sequence. This approach enables us to determine, to some extent, whether a profile shows an occasionally large mean or whether the population mean itself is large. Thus, it will contribute to the refinement of the regional estimation of the ocean energy budget, where only a small amount of turbulence observation data is available., Comment: 18 pages, 14 figures

Published
2019
Full Text
View/download PDF

23. Evaluating optimal bilateral biliary stenting in endoscopic reintervention after initial plastic stent dysfunction for unresectable malignant hilar biliary obstruction: Retrospective cross‐sectional study.

Author

Okuno, Mitsuru, Iwata, Keisuke, Iwashita, Takuji, Mukai, Tsuyoshi, Shimojo, Kota, Ohashi, Yosuke, Iwasa, Yuhei, Senju, Akihiko, Iwata, Shota, Tezuka, Ryuichi, Ichikawa, Hironao, Mita, Naoki, Uemura, Shinya, Yoshida, Kensaku, Maruta, Akinori, Tomita, Eiichi, Yasuda, Ichiro, and Shimizu, Masahito

Subjects
OVERALL survival, MULTIVARIATE analysis, CONFIDENCE intervals, DRAINAGE, RETROSPECTIVE studies
Abstract

Objectives: The placement of plastic stents (PS), including intraductal PS (IS), is useful in patients with unresectable malignant hilar biliary obstruction (UMHBO) because of patency and ease of endoscopic reintervention (ERI). However, the optimal stent replacement method for PS remains unclear. Methods: This retrospective study included 322 patients with UMHBO. Among them, 146 received PS placement as initial drainage (across‐the‐papilla PS [aPS], 54; IS, 92), whereas 75 required ERI. Eight bilateral aPS, 21 bilateral IS, and 17 bilateral self‐expandable metallic stent (SEMS) placements met the inclusion criteria. Rates of technical and clinical success, adverse events, recurrent biliary obstruction (RBO), time to RBO (TRBO), overall survival, and secondary ERI were compared. Results: There were no significant intergroup differences in rates of technical or clinical success, adverse events, RBO occurrence, or overall survival. The median TRBO was significantly shorter in the aPS group (47 days) than IS (91 days; P = 0.0196) and SEMS (143 days; P < 0.01) groups. Median TRBO did not differ significantly between the IS and SEMS groups (P = 0.44). On Cox multivariate analysis, the aPS group had the shortest stent patency (hazard ratio 2.67 [95% confidence interval 1.05–6.76], P = 0.038). For secondary ERI, the median endoscopic procedure time was significantly shorter in the IS (22 min) vs. SEMS (40 min) group (P = 0.034). Conclusions: Bilateral IS and SEMS placement featured prolonged patency after first ERI. Because bilateral IS placement is faster than SEMS placement and IS can be removed during secondary ERI, it may be a good option for first ERI. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

24. WONDER-02: plastic stent vs. lumen-apposing metal stent for endoscopic ultrasound-guided drainage of pancreatic pseudocysts—study protocol for a multicentre randomised non-inferiority trial

Author

Saito, Tomotaka, primary, Takenaka, Mamoru, additional, Kuwatani, Masaki, additional, Doi, Shinpei, additional, Ohyama, Hiroshi, additional, Fujisawa, Toshio, additional, Masuda, Atsuhiro, additional, Iwashita, Takuji, additional, Shiomi, Hideyuki, additional, Hayashi, Nobuhiko, additional, Iwata, Keisuke, additional, Maruta, Akinori, additional, Mukai, Tsuyosh, additional, Matsubara, Saburo, additional, Hamada, Tsuyoshi, additional, Inoue, Tadahisa, additional, Matsumoto, Kazuyuki, additional, Hirose, Sumio, additional, Fujimori, Nao, additional, Kashiwabara, Kosuke, additional, Kamada, Hideki, additional, Hashimoto, Shinichi, additional, Shiratori, Toshiyasu, additional, Yamada, Reiko, additional, Kogure, Hirofumi, additional, Nakahara, Kazunari, additional, Ogua, Takeshi, additional, Kitano, Masayuki, additional, Yasuda, Ichiro, additional, Isayama, Hiroyuki, additional, and Nakai, Yousuke, additional

Published
2024
Full Text
View/download PDF

26. Clinical characteristics of immunoglobulin IgG4-related sclerosing cholangitis: Comparison of cases with and without autoimmune pancreatitis in a large cohort

Author

Furumatsu, Keisuke, Sawai, Shigeaki, Goto, Takuma, Okumura, Toshikatsu, Suzuki, Daisuke, Otsuka, Masayuki, Kobori, Ikuhiro, Tamano, Masaya, Koizumi, Mitsuhito, Hiasa, Yoichi, Kawabe, Naoto, Hirooka, Yoshiki, Yamamoto, Satoshi, Asano, Yukio, Inui, Kazuo, Horiguchi, Akihiko, Watanabe, Hiroyuki, Toya, Daishu, Hatayama, Katsuko, Ueki, Toshiharu, Kinoshita, Norikatsu, Sugimoto, Mitsuru, Ohira, Hiromasa, Mukai, Tsuyoshi, Tomita, Eiichi, Iwata, Keisuke, Shimizu, Shogo, Suetsugu, Jun, Shimizu, Masahito, Tsuji, Keiji, Ishida, Ryoko, Ito, Masanori, Furukawa, Ryutaro, Sakamoto, Naoya, Araki, Masahiro, Tanno, Satoshi, Sakamoto, Yasunari, Ito, Tetsuhide, Takai, Satoshi, Ikeya, Shinichi, Yamada, Takanori, Kudara, Norihiko, Shimizu, Akinori, Hanada, Keiji, Ichiki, Yasunori, Kitada, Hideki, Hifumi, Michio, Kimura, Hiroyuki, Kurosaki, Masayuki, Izumi, Namiki, Sumi, Hajime, Haruta, Jun-ichi, Hayashi, Katsumi, Harada, Ryo, Inoue, Masafumi, Nakamura, Shinichiro, Ito, Tetsuya, Tomishima, Ko, Isayama, Hiroyuki, Oura, Kyoko, Masaki, Tsutomu, Shimokawahara, Naoto, Tanoue, Shirou, Maemura, Kousei, Ido, Akio, Mizushima, Ichiro, Kawano, Mitsuhiro, Yoshida, Katsunori, Naganuma, Makoto, Murata, Miki, Nishio, Akiyoshi, Fujita, Yuji, Teratani, Takuma, Matsubara, Shohei, Tamai, Hironao, Yoshida, Yuu, Azemoto, Ryousaku, Kamata, Ken, Watanabe, Tomohiro, Kurosu, Takahiro, Koizumi, Wasaburou, Fujita, Jun, Seki, Hideyuki, Ueda, Yasuhiro, Fukumoto, Takumi, Kousaki, Takuhiro, Uchida, Kazushige, Ochiai, Toshimasa, Kawasaki, Takeshi, Tanaka, Motohiko, Ishida, Etsuji, Notohara, Kenji, Mori, Hideaki, Mori, Toshiyuki, Kawabata, Hideaki, Miyata, Masatoshi, Sakagami, Junichi, Itoh, Yoshito, Shiokawa, Masahiro, Seno, Hiroshi, Watanabe, Noriko, Naitoh, Itaru, Kataoka, Hiromi, Aoki, Toshinori, Fujishiro, Mitsuhiro, Niihara, Toru, Nishimata, Hiroto, Mitoro, Akira, Yoshiji, Hitoshi, Yoshida, Motoyuki, Ikeda, Masafumi, Tomita, Kengo, Hokari, Ryota, Hayasaka, Kenji, Amano, Yuji, Shioji, Kazuhiko, Hayashi, Kazunao, Terai, Shuji, Nakajima, Michiko, Yamahana, Junya, Matsumoto, Ryusuke, Kikuchi, Hideaki, Kanamori, Akira, Kiriyama, Seiki, Iwatsu, Shinichi, Kato, Yuji, Horiguchi, Shigeru, Yagi, Takahito, Okada, Hiroyuki, Ohkawa, Kazuyoshi, Hirao, Motohiro, Hiramatsu, Naoki, Oza, Noriko, Imamura, Haruo, Baba, Takeshi, Nakano, Shigeru, Shinobi, Tetsuya, Ryozawa, Shomei, Motoya, Masayo, Nakase, Hiroshi, Kinoshita, Noboru, Ito, Kei, Miyake, Tatsuya, Kohge, Naruaki, Tobita, Hiroshi, Joshita, Satoru, Umemura, Takeji, Kawaguchi, Shinya, Ohno, Kazuya, Sonobe, Koichi, Satoh, Akihiko, Shimosegawa, Tooru, Miura, Fumihiko, Yagi, Minami, Sano, Keiji, Tanaka, Atsushi, Kin, Toshifumi, Katanuma, Akio, Koike, Kazuhiko, Miura, Shin, Masamune, Atsushi, Kawashima, Youhei, Kagawa, Tatehiro, Azuma, Seishin, Watanabe, Mamoru, Honjyo, Mitsuyoshi, Itoi, Takao, Honda, Akira, Kobayashi, Katsumasa, Asano, Toru, Kamisawa, Terumi, Mizuno, Suguru, Nishino, Takayoshi, Taniguchi, Hideaki, Tajiri, Kazuto, Yasuda, Ichiro, Tanaka, Yoshiya, Oe, Shinji, Harada, Masaru, Kurata, Masanao, Fukasawa, Mituharu, Enomoto, Nobuyuki, Kawaji, Yuki, Kitano, Masayuki, Nishise, Yuko, Hirakawa, Hidetoshi, Ishizawa, Tetsuya, Ueno, Yoshiyuki, Kaino, Miyuki, Fujimoto, Yuko, Sakaida, Isao, Kubota, Kensuke, Nakazawa, Takahiro, Takikawa, Hajime, Unno, Michiaki, Kawa, Shigeyuki, Nakamura, Seiji, and Okazaki, Kazuichi

Published
2021
Full Text
View/download PDF

33. Efficacy and Safety of Immune Checkpoint Inhibitor Combination Therapy for Dysphagia in Patients with Advanced Esophageal Cancer.

Author

Nakayama, Yurika, Ando, Takayuki, Takagi, Hiroaki, Motoo, Iori, Ueda, Yuko, Sakumura, Miho, Kajiura, Shinya, Takahashi, Saeko, Shimada, Seitaro, Takashima, Yusuke, Fujinami, Haruka, Ogawa, Kohei, Tamura, Hotaka, Hosokawa, Ayumu, and Yasuda, Ichiro

Subjects
DRUG side effects, IMMUNE checkpoint inhibitors, CANCER patients, PULMONARY fibrosis, ESOPHAGEAL cancer, OVERALL survival
Abstract

Background/Objectives: Recently, pembrolizumab plus 5-fluorouracil and cisplatin (FP), nivolumab plus FP, and nivolumab plus ipilimumab have become the first-line treatments for patients with advanced esophageal cancer. However, the treatment efficacy in primary tumors has not been reported. We assessed the outcomes of these treatments in advanced esophageal cancer, specifically focusing on esophageal dysphagia improvements and the primary tumor response. Methods: This retrospective study was conducted between October 2021 and November 2023. We investigated 23 patients with esophageal cancer and dysphagia who received an immune checkpoint inhibitor (ICI) plus FP or nivolumab plus ipilimumab. Results: The median progression-free survival (PFS) was 10.6 months (95% confidence interval [CI]: 9.0–12.5), and the median overall survival was not reached (95%CI: 13.0–NA). Improvement in dysphagia was observed in 19/23 (82.6%) patients, with a median time to improvement of 26 days (range: 15–77 days) and a median dysphagia PFS of 12.6 months (range: 8.1–NA months). Ten patients experienced immune-related adverse events (irAEs): seven had interstitial pneumonia, and three had thyroid dysfunction, pituitary dysfunction, and rash, respectively. Conclusions: Although there was a high frequency of irAEs, ICI for esophageal cancer achieved high response rates and prolonged survival. The observed improvement in dysphagia suggests the potential efficacy of the treatment against primary tumors. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

34. Impact of preS1 Evaluation in the Management of Chronic Hepatitis B Virus Infection.

Author

Hayashi, Yuka, Tajiri, Kazuto, Ozawa, Tatsuhiko, Angata, Kiyohiko, Sato, Takashi, Togayachi, Akira, Nagashima, Izuru, Shimizu, Hiroki, Murayama, Aiko, Muraishi, Nozomu, Narimatsu, Hisashi, and Yasuda, Ichiro

Subjects
HEPATITIS B, HEPATITIS associated antigen, CHRONIC hepatitis B, MONOCLONAL antibodies, EPITOPES
Abstract

Background and Objectives: The measurement of hepatitis B surface antigen (HBsAg) is essential for managing chronic hepatitis B virus infection (CHB). HBsAg consists of three different surface envelope proteins: large, middle, and small HB surface proteins. However, in clinical practice, it is not common to evaluate each of these HB surface proteins separately. Materials and Methods: In this study, we investigated preS1 expression using seven monoclonal antibodies (mAbs) in 68 CHB patients, as well as examining their antigenicity. Results: Although the seven mAbs had been derived from genotype (Gt) C, they could recognize preS1 with Gts A to D. The epitopes were concentrated within the aa33-47 region of preS1, and their antigenicity was significantly reduced by an aa45F substitution. We found that preS1 expression remained consistent regardless of HBsAg levels and different Gts in CHB patients, in contrast to what was observed in SHBs. Conclusions: These results suggest that the antigenic epitope is preserved among different Gts and that the expression pattern of preS1 is altered during CHB, highlighting its vital role in the HBV infection cycle. Our present results suggest preS1 is a promising therapeutic target in CHB. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

35. Prescription Pattern of Anamorelin; a Therapeutic Agent for Cancer Cachexia.

Author

Tambo, Yoshihiro, Kajiura, Shinya, Yoshida, Akihiro, Chikaoka, Shingo, Tanabe, Yuki, Kanai, Nahoko, Takayuki, Ando, Ueda, Akira, Moto, Iori, Nakayama, Yurika, Shima, Tomoko, Matsushita, Yukiko, Mizukami, Tatsuji, Kainuma, Mosaburou, Yasuda, Ichiro, and Hayashi, Ryuji

Subjects
FOOD consumption, RETROSPECTIVE studies, TREATMENT duration, PANCREATIC tumors, CANCER chemotherapy, GHRELIN, PHYSICIAN practice patterns, MEDICAL records, ACQUISITION of data, DRUG efficacy, TUMORS, CACHEXIA, DRUG prescribing, DISEASE complications, CHEMICAL inhibitors
Abstract

Background: The commercial availability of anamorelin, Japan's first therapeutic agent for cancer cachexia in 2021, led to an investigation into its prescription patterns at Toyama University Hospital. Objective: We aimed to analyze anamorelin prescription trends and outcomes among cancer cachexia patients. Methods: A retrospective study from July 2021 to December 2022 examined 88 cases, assessing demographics, cancer types, prescription locations, and meal intake changes. Results: Anamorelin usage was predominant during chemotherapy, especially for pancreatic cancer in outpatient settings. Approximately 30% experienced increased meal intake. Chemotherapy-initiated cases had a longer median duration (55 days) compared with best supportive care only cases (12 days). Conclusion: Anamorelin demonstrated significant prescription patterns, particularly during chemotherapy for pancreatic cancer in outpatient settings, suggesting potential efficacy enhancements when administered with chemotherapy in cancer cachexia management. The study underscores the importance of tailored approaches to optimize anamorelin's therapeutic benefits. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

36. Postprocedure serum amylase or lipase levels predict postendoscopic retrograde cholangiopancreatography pancreatitis: Meta‐analysis of diagnostic test accuracy studies and utility assessment.

Author

Hirota, Morihisa, Itoi, Takao, Morizane, Toshio, Koiwai, Akinobu, Yasuda, Ichiro, Ryozawa, Shomei, Mukai, Shuntaro, Ikeura, Tsukasa, Irisawa, Atsushi, Iwasaki, Eisuke, Katanuma, Akio, Kitamura, Katsuya, Takenaka, Mamoru, Ito, Tetsuhide, Masamune, Atsushi, Mayumi, Toshihiko, and Takeyama, Yoshifumi

Subjects
LIPASES, AMYLASES, PANCREATIC enzymes, DIAGNOSIS methods, ENDOSCOPIC retrograde cholangiopancreatography, PANCREATITIS
Abstract

Objectives: We aimed to clarify the clinical utility of measuring serum pancreatic enzymes after endoscopic retrograde cholangiopancreatography (ERCP) for the purpose of predicting post‐ERCP pancreatitis (PEP) by a meta‐analysis of diagnostic test accuracy studies. Methods: Studies on the prediction accuracy of PEP by serum amylase or lipase measured at 2, 3, and 4 h after ERCP were collected. A literature search was performed in PubMed and the Cochrane Library database for studies published between January 1980 and March 2023. The quality of individual studies was evaluated using the Quality Assessment of Diagnostic Accuracy Studies‐2. Data were analyzed using Meta‐DiSc 2.0 software. Results: We searched the databases and identified 20 observational studies (12,313 participants). PEPs were defined according to criteria by Cotton or modified Cotton, revised Atlanta criteria, or the Japanese criteria. Meta‐analysis of eight studies (4389 participants) showed a pooled sensitivity of 71.1% (95% confidence interval [CI] 56.1–82.5) and pooled specificity of 91.2% (95% CI 85.9–94.6) for the serum amylase cut‐off value at 3 times the upper limit of normal (ULN). Another meta‐analysis of five studies (1970 participants) showed a pooled sensitivity of 85.8% (95% CI 61.9–95.7) and pooled specificity of 85.3% (95% CI 81.9–88.1) for the serum lipase cut‐off value at 3 times ULN. Conclusion: Despite a high risk of bias due to various reference standards, this updated meta‐analysis and the utility assessment by a decision tree showed the utility of serum amylase or lipase levels more than 3 times ULN measured 2–4 h after ERCP for predicting PEP. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

39. International consensus guidelines on interventional endoscopy in chronic pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with the International Association of Pancreatology, the American Pancreatic Association, the Japan Pancreas Society, and European Pancreatic Club

Author

Kitano, Masayuki, Gress, Thomas M., Garg, Pramod K., Itoi, Takao, Irisawa, Atsushi, Isayama, Hiroyuki, Kanno, Atsushi, Takase, Kei, Levy, Michael, Yasuda, Ichiro, Lévy, Phillipe, Isaji, Shuiji, Fernandez-Del Castillo, Carlos, Drewes, Asbjørn M., Sheel, Andrea R.G., Neoptolemos, John P., Shimosegawa, Tooru, Boermeester, Marja, Wilcox, C. Mel, and Whitcomb, David C.

Published
2020
Full Text
View/download PDF

41. CA125 Kinetics as a Potential Biomarker for Peritoneal Metastasis Progression following Taxane-Plus-Ramucirumab Administration in Patients with Advanced Gastric Cancer

Author

Ueda, Akira, primary, Yuki, Satoshi, additional, Ando, Takayuki, additional, Hosokawa, Ayumu, additional, Nakada, Naokatsu, additional, Kito, Yosuke, additional, Motoo, Iori, additional, Ito, Ken, additional, Sakumura, Miho, additional, Nakayama, Yurika, additional, Ueda, Yuko, additional, Kajiura, Shinya, additional, Nakashima, Koji, additional, Harada, Kazuaki, additional, Kawamoto, Yasuyuki, additional, Komatsu, Yoshito, additional, and Yasuda, Ichiro, additional

Published
2024
Full Text
View/download PDF

43. The Efficacy and Safety of Nivolumab Plus mFOLFOX6 in Gastric Cancer with Severe Peritoneal Metastasis

Author

Nakayama, Yurika, primary, Ando, Takayuki, additional, Takahashi, Naoki, additional, Tsukada, Kenichiro, additional, Takagi, Hiroaki, additional, Goto, Yuno, additional, Nakaya, Atsuko, additional, Nakada, Naokatsu, additional, Yoshita, Hiroki, additional, Motoo, Iori, additional, Ueda, Akira, additional, Ueda, Yuko, additional, Sakumura, Miho, additional, Kajiura, Shinya, additional, Ogawa, Kohei, additional, Hosokawa, Ayumu, additional, and Yasuda, Ichiro, additional

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results